Tower Research Capital LLC (Trc) Seelos Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.22 $4,372 - $8,082	6,625 Added 370.73%	8,412 $10,000
Q1 2023 May 09, 2023	BUY	$0.59 - $1.04 $1,008 - $1,778	1,710 Added 2220.78%	1,787 $1,000
Q3 2022 Nov 10, 2022	SELL	$0.65 - $278.68 $5,339 - $2.29 Million	-8,214 Reduced 99.07%	77 $0
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $4,091 - $7,460	-8,022 Reduced 49.18%	8,291 $6,000
Q1 2022 May 12, 2022	SELL	$0.84 - $1.71 $11,156 - $22,712	-13,282 Reduced 44.88%	16,313 $14,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $29,602 - $44,310	18,618 Added 169.61%	29,595 $48,000
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $275 - $471	-163 Reduced 1.46%	10,977 $26,000
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $10,649 - $25,494	-4,034 Reduced 26.58%	11,140 $29,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $20,484 - $75,718	15,174 New	15,174 $76,000
Q4 2020 Feb 16, 2021	SELL	$0.74 - $2.01 $1,264 - $3,435	-1,709 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.6 - $1.25 $3,756 - $7,825	-6,260 Reduced 78.55%	1,709 $2,000
Q2 2020 Aug 13, 2020	BUY	$0.42 - $1.51 $3,346 - $12,033	7,969 New	7,969 $8,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.